{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:19:13Z","timestamp":1783383553071,"version":"3.54.6"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Sterna Biologicals GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.1093\/ibd\/izag077","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:44:18Z","timestamp":1778327058000},"page":"1426-1427","source":"Crossref","is-referenced-by-count":0,"title":["Authors\u2019 response to letter to editor\u2014silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-8433","authenticated-orcid":false,"given":"Raja","family":"Atreya","sequence":"first","affiliation":[{"name":"Medical Department 1, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum Immuntherapie, DZI, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4344-1474","authenticated-orcid":false,"given":"Markus F","family":"Neurath","sequence":"additional","affiliation":[{"name":"Medical Department 1, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum Immuntherapie, DZI, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2026070620125139100_izag077-B1","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izag046","article-title":"Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial","author":"Atreya","year":"2026","journal-title":"Inflamm Bowel Dis"},{"key":"2026070620125139100_izag077-B2","article-title":"Silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis","author":"Costa CMM","year":"2026","journal-title":"Inflamm Bowel Dis"},{"key":"2026070620125139100_izag077-B3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.cgh.2024.01.026","article-title":"Biomarkers for personalizing IBD therapy: the quest continues","volume":"22","author":"Atreya","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026070620125139100_izag077-B4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"2026070620125139100_izag077-B5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/j.gastro.2016.09.005","article-title":"Rectal delivery of a DNAzyme that specifically blocks the transcription factor GATA3 and reduces colitis in mice","volume":"152","author":"Popp","year":"2017","journal-title":"Gastroenterology"},{"key":"2026070620125139100_izag077-B6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S2468-1253(18)30265-6","article-title":"Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease","volume":"3","author":"Atreya","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026070620125139100_izag077-B7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/ecco-jcc\/jjy004","article-title":"Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2026070620125139100_izag077-B8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.3462","article-title":"In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn\u2019s disease","volume":"20","author":"Atreya","year":"2014","journal-title":"Nat Med"},{"key":"2026070620125139100_izag077-B9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/ecco-jcc\/jjad164","article-title":"NLRP3 inhibition leads to impaired mucosal fibroblast function in patients with inflammatory bowel diseases","volume":"18","author":"Weber","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026070620125139100_izag077-B10","doi-asserted-by":"publisher","first-page":"103582","DOI":"10.1016\/j.eclinm.2025.103582","article-title":"An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease","volume":"89","author":"Solitano","year":"2025","journal-title":"EClinicalMedicine"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/7\/1426\/68268189\/izag077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/7\/1426\/68268189\/izag077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:12:58Z","timestamp":1783383178000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/7\/1426\/8675911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,5,11]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag077","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,11]]}}}